3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Pain
13
Pain, Postoperative
10
Neoplasms
8
Agnosia
8
Multiple Myeloma
7
Cancer Pain
5
Breast Neoplasms
5
Lung Neoplasms
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Lymphoma, Non-Hodgkin
3
Head and Neck Neoplasms
3
Colonic Neoplasms
3
Trigger Finger Disorder
2
Lymphoma
2
Hodgkin Disease
2
Hematologic Neoplasms
2
Ganglion Cysts
2
De Quervain Disease
2
Chronic Pain
2
Burkitt Lymphoma
2
Acute Pain
2
Vomiting
1
Uterine Cervical Neoplasms
1
Thyroid Nodule
1
Thyroid Neoplasms
1
Thyroid Diseases
1
Strabismus
1
Squamous Cell Carcinoma of Head and Neck
1
Skin Neoplasms
1
Renal Insufficiency
1
Interventions
Letrozole
4
Anastrozole
4
Surveys and Questionnaires
3
Aromatase Inhibitors
3
exemestane
2
Exercise
2
Educational Status
2
Acupuncture Therapy
2
methyl hydroxyethyl cellulose
1
guizhi-shaoyao-zhimu decoction
1
Yoga
1
Walking
1
Vitamin B 12
1
Therapeutics
1
Testosterone
1
Tamoxifen
1
Occupational Therapy
1
Hyaluronic Acid
1
Glucosamine
1
Glucaric Acid
1
Gabapentin
1
Fish Oils
1
Fatty Acids, Omega-3
1
Docosahexaenoic Acids
1
Diphosphonates
1
Diet Therapy
1
Denosumab
1
Curcumin
1
Chondroitin Sulfates
1
Chondroitin
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Arthralgia
×
Acetaminophen
×
Clear all
NCT04408560
2022-09-19
ARHOMA2
Institut Jean-Godinot
Phase NA
Completed
140 enrolled